Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(12 sites) United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California University of California, San Francisco, San Francisco, California University of California, Los Angeles, Santa Monica, California Mayo Clinic - Jacksonville, Jacksonville, Florida Sylvester Comprehensive Cancer Center, Univ of Miami, Miami, Florida Florida Cancer Specialists - Sarasota, Sarasota, Florida United Theranostics, Glen Burnie, Maryland Dana-Farber Cancer Institute, Boston, Massachusetts Mayo Clinic - Rochester, Rochester, Minnesota Memorial Sloan Kettering Cancer Center, New York, New York MD Anderson, Houston, Texas Huntsman Cancer Institute, Salt Lake City, Utah